Research Notes

Dexterity through Dextrose For osteoarthritis sufferers, injections of a sugar solution could be much more than placebo, a new study suggests (K.D. Reeves et al., "Randomized prospective double-blind prolotherapy for knee osteoarthritis with or without ACL laxity," Alternative Therapies in Health and Medicine, 6:68-80, March 2000). Prolotherapy, the injection of growth factors or their stimulators, is aimed at inducing an inflammatory response, to effect tissue repair or growth. A dextrose solut

Written bySteve Bunk
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Dexterity through Dextrose

For osteoarthritis sufferers, injections of a sugar solution could be much more than placebo, a new study suggests (K.D. Reeves et al., "Randomized prospective double-blind prolotherapy for knee osteoarthritis with or without ACL laxity," Alternative Therapies in Health and Medicine, 6:68-80, March 2000). Prolotherapy, the injection of growth factors or their stimulators, is aimed at inducing an inflammatory response, to effect tissue repair or growth. A dextrose solution commonly is used to create temporary cellular stress, but in this study, the concentration of dextrose was only 10 percent, too low to cause inflammation. This not only protected double blinding, but also tested whether the elevation of extracellular glucose that is known to cause proliferation of growth factors in human cells would provide effective prolotherapy without an inflammatory mechanism. Sixty-eight of 77 patients with osteoarthritis in one or both knees, who were randomly assigned to either the treatment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies